The Biosimilar Patent Dance, Labeling Exclusivity And The Power Of Unintended Innovation
Executive Summary
As brand firms are learning with biosimilars, laws can turn out in unexpected ways – but there may well be some pleasant surprises in the 21st Century Cures legislation.